Overview
TEVA market data
Price History
TEVA price chart · 1M
- O
- 38.97
- H
- 39.48
- L
- 38.32
- C
- 38.58
- Vol
- 259,818.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $38.97
- Previous Close
- $39.18
- Day High
- $39.48
- Day Low
- $38.32
- 52 Week High
- $39.48
- 52 Week Low
- $37.12
- 7 Day Return
- +0.65%
- 30 Day Return
- +0.65%
- 90 Day Return
- +0.65%
- 1 Year Return
- +0.65%
- Daily Notional Volume
- $10M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 62.18 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $1.21 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.47 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 4.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $6,082.00 – $11,900.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $134.5B · P/B 4.79 · P/S 2.55.
Company News
10 captured
Lilly Builds Neuroscience into a New Long-Term Growth DriverZacks Investment Research ·
Ulcerative Colitis Market Outlook: 5 Late-Stage Drug Candidates to Watch | DelveInsightGlobenewswire Inc ·
Teva Announces Launch of Offering of Senior NotesGlobenewswire Inc ·